US Patent Issued to Regents of the University of Minnesota on March 31 for "Treatments administering chimeric IgG Fc receptor comprising an extracellular domain of CD64" (Minnesota Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,138, issued on March 31, was assigned to Regents of the University of Minnesota (Minneapolis).

"Treatments administering chimeric IgG Fc receptor comprising an extracellular domain of CD64" was invented by Jianming Wu (Plymouth, Minn.), Bruce Kenneth Walcheck (Lino Lakes, Minn.), Robert Harrison Hullsiek (Minneapolis), Yungfang Li (Minneapolis) and Hemant Kumar Mishra (Minneapolis).

According to the abstract* released by the U.S. Patent & Trademark Office: "A recombinant immune cell expresses a heterologous IgG Fc receptor. In some embodiments, the heterologous IgG Fc receptor can be a chimeric IgG Fc receptor. Generally, the chimeric IgG Fc receptor includes an extracellular do...